UNSPSC 85813507: Introduction of other therapeutic substance into subcutaneous tissue, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other therapeutic substance into subcutaneous tissue, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E013GC

UNSPSC 85813507, a Commodity code for introduction of other therapeutic substance into subcutaneous tissue via percutaneous approach, shows minimal alignment with recent state and local procurement activity. The nominal code scope—a clinical procedure for subcutaneous drug delivery—does not match the work actually being solicited under this code tag in the state and local market. Recent opportunities posted under this code encompass virtual urgent care services, general medical services contracts, Program of All Inclusive Care for the Elderly (PACE) operations, occupational health services, cancer registry support, medical device supply and services, emergency staffing, employee health clinic administration, and various specialty clinical services such as psychological evaluation, independent medical evaluation, and radiology reads. These opportunities span distinct clinical service lines, equipment provision, and administrative health functions rather than a specific procedural intervention. The issuing bodies include state health authorities, county governments, municipal health systems, county sheriffs' offices, school districts, and specialized health authorities across California, Georgia, Nevada, Colorado, Florida, Arizona, Texas, Kansas, and Oregon.

The code shows no recent opportunities directly aligned with subcutaneous therapeutic substance injection procedures. Geographic spread spans multiple states with active health procurement across the West (California, Nevada, Colorado), Southeast (Georgia, Florida), Southwest (Arizona, Texas), Midwest (Kansas), and Pacific Northwest (Oregon). State health authorities and public health systems dominate the issuer mix, with repeat activity from Nevada Health Authority, Colorado Department of Human Services, Texas Health and Human Services Commission, and county-level health systems. Representative recent solicitations include Nevada Health Authority's PACE operations RFP (due December 10, 2026) establishing integrated senior care services at capitated rates across multiple Nevada service areas; the City of Phoenix's cancer screening services RFP (due February 2, 2026, for July 1, 2027 commencement) targeting high-volume first-responder populations with comprehensive oncologic and preventive imaging; and Texas HHSC's radiology and EKG read services IFB (due July 20, 2026) providing diagnostic interpretation across 24 state facilities. This code appears to be misapplied to a broader class of clinical and health administrative services rather than reflecting genuine procurement for the specified therapeutic procedure.